This study seeks the validation of a clinically useful brief screening and assessment instrument to identify patients with problematic substance use or a SUD to facilitate brief interventions and referrals to appropriate treatment. Specifically, this study’s aims to 1) develop a two-stage brief screening and assessment instrument to detect unhealthy use of tobacco, alcohol, prescription, and illicit drugs among primary care patients; 2) examine the validity of this 2-stage instrument by comparing it to reference standard measures for substance use, problematic use, and substance use disorders; and 3) determine the feasibility of a self-administered 2-stage tool and an interviewer-administered 2-stage tool in US General Medical Settings.
Principal Investigator(s)
Robert Schwartz , M.D.
Program Director
Friends Research Institute, Inc.
1040 Park Avenue, Suite 103
Baltimore, MD 21201
rschwartz@friendsresearch.org
Jennifer McNeely, M.D., M.S.
Assistant Professor
New York University School of Medicine
Department of Population Health
227 East 30th Street, Room 711
New York, NY 10016
jennifer.mcneely@nyumc.org
Li-Tzy Wu, Sc.D., R.N., M.A.
Professor
Department of Psychiatry and Behavioral Sciences
Duke University Medical Center
BOX 3903
Durham, NC 27710
litzy.wu@duke.edu
Participating Sites
- Chase Brexton Health Services, Maryland
- Virginia Commonwealth University, Institute for Drug and Alcohol Studies, Virginia
- Bellevue Primary Care, NYU School of Medicine, Department of Population Health, New York
- Cabarrus Health Alliance, North Carolina
- Novant Kannapolis Family Medicine, North Carolina